Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
10don MSN
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback